The effects of Cl-and Ca2+ on the specific binding of L-glutamate and L-aspartate to synaptic plasma membranes (SPMs) were examined. At a concentration of 2.5 mM, CaClz augmented Lglutamate binding 3.34-fold and modified its pharmacological specificity, whereas L-aspartate binding was unaffected. Kinetic analyses of the inhibition of L-glutamate binding by the a-amino-w-phosphonic acid derivatives of propionic (APP), butyric (APB), and valeric (APV) acids demonstrated that, in the presence of CaC12, these homologues competed for the same L-glutamate binding site with Ki values of 16 PM (APB), 39 PM (APV), and >l mM (APP); the L isomer of APB was 15-fold more potent than the D form (Ki values, 5 and 75 PM, respectively). Hill plots indicated an absence of cooperative interactions. These Ki values are in close agreement with those determined electrophysiologically for the antagonism of perforant path-granule cell synaptic transmission in the rat dentate gyrus in vitro (Koerner, J. F., and C. W. Cotman (1981) Brain Res. 216: 192-198). In the presence of CaCl2, approximately 80% of the L-glutamate binding sites were sensitive to inhibition by the phosphonic acid derivatives, and experiments with APB indicated that the insensitive sites could be equated with the CaClz-independent sites. Investigations with Cl-and Ca2+ separately and in combination suggested that Cl-is necessary to unmask the APB-sensitive sites and that Ca2+ is required to reveal the full extent of this response. Further studies showed that the Cll/Ca"+-dependent APB-sensitive L-glutamate binding sites are enriched in SPMs (relative to total particulate and crude mitochondrial fractions) and that these sites are sensitive to inhibition by a number of compounds with agonist or antagonist properties at excitatory amino acid receptor sites. These data indicate that Cl-and Ca2+ unmask a pharmacologically distinct population of L-glutamate binding sites which are of physiological significance for acidic amino acid-mediated synaptic transmission in the brain.
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Electrophysiological
studies have demonstrated the presence of multiple excitatory amino acid receptor types on neurons of the mammalian central nervous system (CNS).4 Examination of a large number of excitants and ' APB, 2-amino-4-phosphonobutyrate; APP, DL-2-amino-3-their sensitivity to antagonism by D-cY-aminoadipate (DaAA) and glutamate diethyl ester has led to a classification scheme for these receptors based on the most selective agonists, quisqualate, N-methyl-n-aspartate (NMDA), and kainate; L-glutamate and L-aspartate are less specific but show some preference for the quisqualate and NMDA receptor types, respectively (see recent re- Cotman et al., 1981; McLennan, 1981; Watkins and Evans, 1981) . Parallel biochemical investigations are more limited, in part due to the lack of a wide range of radiolabeled ligands, although recent experiments have identified distinct binding sites for L-glutamate, L-aspartate, and kainate in synaptic membrane fractions isolated from CNS tissues (Foster and Roberta, 1978; London and Coyle, 1979; Michaelis et al., 1980; Sharif and Roberts, 1981; Foster et al., 1981b) . Pharmacological analyses, however, have revealed a number of discrepancies between the sites labeled in binding assays and those examined electrophysiologically (see Roberts, 1981) , and it has proven difficult to equate conclusively binding sites with physiological synaptic receptors. One significant methodological difference between these two types of study is the composition of the assay medium. Binding assays are commonly conducted using buffers alone (e.g., HEPES-KOH or Tris-Cl), whereas electrophysiological experiments either are performed in viuo or, for in vitro work, employ a complex medium of similar ionic composition to that occurring physiologically in the cerebrospinal fluid or extracellular space. Recent investigations have demonstrated that a number of ions are capable of modifying the interaction between neurotransmitters and their receptors. For example, Na' regulates the agonist-antagonist conformation of opiate (Pert and Snyder, 1974) and noradrenaline receptors (Greenberg et al., 1978) , Mg2+ acts as an antagonist (although indirectly) at NMDA sites (Ault et al., 1980 ), Ca2+ appears necessary for binding at the y-aminobutyrate (GABA) B site (Hill and Bowery, 1981) ) and a number of anions (notably Cl-) modify the interaction of GABA antagonists and benzodiazepines with their recognition sites (see Olsen, 1981) . Ca2+ also has been shown to increase the number of Na+-independent L-glutamate binding sites in synaptic membranes (Michaelis et al., 1974; Baudry and Lynch, 1979; Vargas and Costa, 1981; Foster et al., 1981a, b) , and this effect has been attributed to the activation of an intracellularly located membranebound protease which exposes additional binding sites (Baudry and Lynch, 1980; Vargas et al., 1980) . Recent investigations in this laboratory demonstrate further that Cl-exerts a potent stimulatory effect on L-glutamate binding and that Cl-and Ca"+ act in concert to enhance the binding of this ligand (Mena et al., 1982) .
In the present study, we have examined the pharmacological specificity of L-glutamate and L-aspartate binding to synaptic plasma membranes (SPMs) in the presence and absence of Ca"' and Cl-. We present a detailed analysis of the inhibition of L-glutamate binding by a homologous series of phosphonic acid derivatives and show that the pharmacological specificity observed in the presence of Ca2+ and Cl-is similar to that determined electrophysiologically at the perforant path-granule cell synapse in the hippocampal slice in vitro (Koerner and Cotman, 1981) , where glutamate is probably the neurotransmitter (Cotman and Nadler, 1981) . Our data indicate ( I ) that there are two distinct populations of Na'-independent L-glutamate binding sites in SPMs which can be distinguished on the basis of their Cl-and Ca2+ dependence and their pharmacological properties and (2) that Cl-/C&'-dependent L-glutamate binding sites are of physiological significance for acidic amino acidmediated synaptic transmission in the CNS. Preliminary results from this study have been reported elsewhere (Fagg et al., 1981; Monaghan et al., 1981 Isolation of synaptic plasma membranes (SPMs) and other subcellular fractions. SPMs and other subcellular fractions were isolated from rat forebrains (SpragueDawley, aged 30 to 60 days) using a modification of the method of Cotman and Taylor (1972) as recently described in detail (Foster et al., 1981a) . Briefly, a crude mitochondrial (Pz) fraction was prepared, lysed using hypotonic buffer, treated with iodonitrotetrazolium violet (INT; to facilitate the separation of mitochondria from SPMs; see Cotman and Taylor, 1972) , and further subfractionated by discontinuous sucrose density gradient centrifugation. The myelin (floating on 0.95 M sucrose) and mitochondrial fractions (pellet in 1.3 M sucrose) were discarded, and SPMs were recovered from the 0.95 ~/1.3 M sucrose interface. These were diluted with 0.2 mM HEPES-KOH buffer (pH 7.4), pelleted by centrifugation at 55,000 x g for 20 min, and then washed three more times in the same manner (resuspension in buffer and centrifugation). Each wash involved an approximately lOO-fold dilution of the pellet. In some experiments, SPMs were treated with ethylenediaminetetra-acetate (EDTA) to remove tightly bound divalent cations. In these cases, membranes were resuspended (1 mg of protein/ml) in a solution of 4 mM EDTA and 0.2 mM HEPES-KOH (pH 7.4), incubated at 20°C for 45 min, and washed four times as described above; control membranes were incubated in the absence of EDTA and washed in the same manner.
SPMs were used for all binding assays unless otherwise Vol. 2, No. 7, July 1982 stated. A small number of assays were performed with the total particulate, lysed Pz, and INT-treated Pz (INT-P2) fractions. In these cases, fractions were lysed osmotically and then washed three or four times as described for SPMs. All fractions were finally resuspended in 50 mM HEPES-KOH buffer (pH 7.4) for storage on ice overnight (Foster et al., 1981a (Foster et al., 1981a) . With the exception of the Scatchard analyses shown in Figure la , radiolabeled ligands were used at a concentration of 50 nM, and specific binding was defined as that which could be displaced by a 0.5 mM concentration of the nonradiolabeled ligand. CaClz (2.5 mM) and other compounds were included in the assay buffer (50 mM HEPES-KOH, pH 7.4) as indicated under "Results."
Thin layer chromatography (cellulose plates; mobile phase 1-butanol:acetic acid:water, 12:3:5 by volume) of the radioactivity bound to SPMs showed that greater than 95% co-migrated with the parent amino acid, indicating that metabolism did not occur to any appreciable extent during the assay.
Results
Basal binding levels and the effects of CaCh. The basal levels of L-glutamate and L-aspartate binding in SPM fractions were 1.94 + 0.27 pmol/mg of protein and 0.83 -+ 0.15 pmol/mg of protein, respectively (means f SEM of data from 13 separate experiments; 50 nM ligand concentration).
Inclusion of 2.5 mM CaCla in the assay buffer augmented the binding of L-glutamate 3.34 + 0.44-fold (p < 0.01; n = 13; paired t test), whereas L-aspartate binding was unchanged (1.14 + 0.06-fold; n = 13; p > 0.1).
Effects of CaClz on the pharmacology of L -glutamate and L-aspartate binding. The effect of CaC12 on the pharmacological specificity of L-glutamate and L-aspartate binding to SPMs was examined initially using a homologous series of acidic amino acid analogues-the a-amino-w-phosphonic acid derivatives of propionic (APP), butyric (APB), and valeric (APV) acids-which exhibit activity at excitatory amino acid receptor sites in the mammalian CNS (White et al., 1979; Davies and Watkins, 1979; Davies et al., 1981; Koerner and Cotman, 1981) . Table I shows that, in the absence of added ions, the degree of inhibition of L-glutamate binding by the phosphonic acid derivatives (0.1 mM concentration) increased with chain length, with DL-APV the most effective of these homologues.
However, in the presence of CaC12, DL-APB was a significantly (p c 0.1) more effective inhibitor than in the absence of this ion such that these compounds now could be ordered APB > APV > APP as inhibitors of L-glutamate binding. Further experiments with the stereoisomers of APB suggested that the inhibitory activity of these compounds resided principally with Additional experiments using the stereoisomers of glutamate and aspartate (0.1 mM concentration) suggested that CaCL did not alter the inhibitory potencies of the L isomers (see also next section), but it did increase the effectiveness of the D forms (p < 0.05 for D-glutamate; Table I ). In the case of L-aspartate binding, the L isomers of both glutamate and aspartate were better inhibitors than their D enantiomers, and CaCL had no effect on the activity of any of these substances.
Kinetics of inhibition of L-glutamate binding byphosphonic acid derivatives in the presence of CaCh. Scatchard analyses indicated that, at low concentrations (10
DL-APB inhibited L-glutamate binding competitively (no change in B,,,; increase in apparent KD), whereas the inhibition kinetics deviated from competitive type behavior at higher concentrations (Fig. la) . More extensive analyses, using a wide range of inhibitor concentrations, demonstrated that this deviation was due to the presence of a DL-APB-insensitive component of L-glutamate binding (i.e., a glutamate binding component which persisted in the presence of high concentrations of APB; see Fig. lb ). Similar plots indicated that DL-APB, its stereoisomers, and DL-APV all competed with different affinities for the same L-glutamate binding site, which represented about 80% of the L-glutamate bound (Fig.  lb) . The Ki values calculated from these plots showed that the order of potency for the inhibition of L-glutamate binding was APB > APV > APP, with L-APB 15-fold more potent than its D enantiomer (Table II) C is the inhibitor concentration (which ranged from 1 to 1000 pM in these experiments), F is the free concentration of L-["HIglutamate (50 nM), and Ko is its dissociation constant. Lines of best fit were determined by linear regression analysis and KI values were calculated as described in the legend to Table II . Each plot is representative of those obtained in two to five separate experiments (see Table II for additional details), and each point is the mean of triplicate determinations.
inhibitor of NMDA-induced responses in the spinal cord (Davies et al., 1981) , these values are in close agreement with those determined for the antagonism of perforant path-evoked field potentials in the outer molecular layer of the rat dentate gyrus in vitro (Koerner and Cotman, 1981 ; see Table II ). Similar analyses using L-glutamate as the inhibitor of binding yielded a KI value of 0.75 PM, which is the same as that determined in the absence of CaC12 (0.77 PM) and is in close agreement with KD estimates for radiolabeled L-glutamate in a variety of synaptic membrane preparations (Foster and Roberts, 1978; Baudry and Lynch, 1979; Foster et al., 1981b) . Hill coefficients for the phosphonic acid derivatives and for Lglutamate (0.90 to 1.10, Table II ) indicated an absence of cooperative interactions. In order to determine whether the approximately 20% APB-resistant L-glutamate binding sites observed in the presence of CaClz could be equated with the CaC&in-dependent sites, a comparison was made of the residual L-glutamate binding after inhibition by APB in the two assay conditions (+CaC12). In the presence of 0.1 mM L-APB (a concentration giving near maximal inhibition), the amount of L-glutamate bound to SPMs was similar whether CaCl* was included in the assay buffer or not (zero CaCl*, 1.51 & 0.45 pmol/mg of protein; 2.5 mM CaC12, 1.70 f 0.47 pmol/mg of protein; n = 6) despite the observation that the specific L-glutamate binding was augmented more than 3-fold by these ions. Hence, the increase in L-glutamate binding induced by CaClz appears to represent the introduction of a new population of L-glutamate binding sites which are selectively sensitive to inhibition by APB.
Effects of Cl-and Ca'+ alone and in combination on APB-sensitive L -glutamate binding. Recent observations in this laboratory have shown that Cl-stimulates L-glutamate binding to SPMs and that Ca2+ acts only in the presence of Cl-to enhance this response further (Mena et al., 1982) . The pharmacological studies reported here were conducted in the presence of both Cl-and Ca"+ (as CaClz), and the data presented in the preceding section indicate that the additional binding sites revealed by these ions in combination were of the APB-sensitive type. Further experiments to define the role of each ion demonstrated that the KI values for the inhibition of Lglutamate binding by DL-APB were similar (parallel lines in Scatchard plots) both when 5 mM Cl-(as Tris-Cl) and when 5 mM Cl-plus 2.5 mM Ca"+ (as 2.5 mM CaClz) were included in the assay buffer (Fig. 2) . However, almost 2-fold more APB-sensitive sites were apparent in the presence of CaC12 than in the presence of Cl-alone. In the presence of only 2.5 mM Ca"' (added as the acetate salt) or in the absence of added ions, a small number of APBsensitive L-glutamate binding sites were detected ( Fig. 2 ; Table I ) possibly due to the presence of residual Cl-and/ or Ca2+ in the SPM preparation.
Additional experiments using a single concentration (0.2 mM) of DL-APB to assess APB-sensitive L-glutamate binding indicated that either pretreatment of SPMs with EDTA (see "Materials and Methods") or inclusion of 10 mM EDTA in the assay buffer (I) abolished the small degree of APB sensitivity observed in the absence of added ions (see Table I ) and (2) reduced (but did not abolish) the number of APB-sensitive sites induced by 5 mM Cl-(data not shown). Together, these data suggest that Cl-is necessary to unmask the APB-sensitive population of L-glutamate binding sites in SPMs and that Ca" is required to reveal the full extent of this response.
Generalpharmacological characteristics of CaClz-dependent L-glutamate binding. In addition to the phosphonic acid derivatives, the pharmacological specificity of L-glutamate binding in the presence of CaClz was assessed using a number of analogues which, through electrophysiological studies, have been proposed as agonists or antagonists of the various excitatory amino acid receptor classes (see, for example, McLennan, 1981; Watkins and Evans, 1981) . At a concentration of 0.1 mM, quisqualate, ibotenate, DcyAA, and L&A inhibited greater than 70% of the L-glutamate binding in the pres- ence of CaC12 and were significantly more effective than in the absence of these ions (Table III) . At the opposite end of the potency range, NMA, kainate, and PDA displaced less than 15% of the binding in the presence of CaC12; the effect of PDA was significantly lower than in the absence of CaC12, whereas kainate and NMA inhibitions were unchanged (although the mean value for NMA was somewhat lower in the CaC12 condition). The remaining compounds (ADCP, yDGG, and DAP) produced inhibitions in the presence of CaClz of 40 to 65%; CaC12 markedly increased the effectiveness of ADCP and DAP, whereas the potency of yDGG was unaffected by these ions (Table III) . GABA and its analogue, baclofen, at concentrations of 0.1 mM, were ineffective as displacers of L-glutamate binding both in the presence and absence of CaC12 (data not shown). Subcellular localization of CaCh-dependent (APBsensitive) L-glutamate binding sites. The data presented above suggest that CaClz-dependent L-glutamate binding sites are of functional significance at acidic amino acidusing synapses in the brain, and therefore, one would predict a higher density of these sites in synaptic membranes than in other cellular organelles. Analyses of total particulate, crude mitochondrial (Pz), and SPM fractions indicated a progressive enrichment of CaCkdependent (APB-sensitive) sites as nonsynaptic material was removed, with the density of sites in SPMs being more than 2-fold greater than in the particulate fraction (Table  IV) . Table IV also shows that INT, a mild oxidizing'agent which is used to facilitate the separation of mitochondria from SPMs (see "Materials and Methods"), does not affect the binding of L-glutamate to CaClz-dependent (APB-sensitive) sites (p < 0.2 between P2 and INT-P2 fractions; paired t test).
Discussion
The findings of this study are of considerable significance both for investigations of glutamate binding and for an understanding of the molecular mechanisms involved in acidic amino acid-mediated synaptic transmission. Our data provide the first evidence for the identity of a population of SPM-located L-glutamate binding sites with receptors at a specific synapse and suggest that Cland Ca2+ ions serve important functions at acidic amino acid-using synapses in the CNS.
The observations presented here demonstrate that there are two populations of Na'-independent L-glutamate binding sites in SPMs which can be distinguished on the basis of their Cl-and Ca2+ requirements and their pharmacological characteristics, although & (Foster et al., 1981b) and KI determinations (this paper) in the presence and absence of CaC12 suggest that the affinities of these sites for L-glutamate are similar. The Cll/Ca'+-dependent sites described in this report exhibit a number of properties indicative of a role as synaptic receptors. Fundamental to this postulate is the observation that their pharmacological specificity (assessed using a series of phosphonic acid derivatives) is in close agreement with that determined electrophysiologically at the perforant path-granule cell synapse in the rat dentate gyrus (Koerner and Cotman, 1981; see Table II) , where glutamate is probably the neurotransmitter (Cotman and Nadler, 1981) . In addition, the sites were sensitive to inhibition by a number of compounds with agonist (e.g., quisqualate, ibotenate, and ADCP) or antagonist (e.g., D&A and APB) activity at acidic amino acid receptor sites (see Watkins and Evans, 1981) . The C11/Ca2+-dependent sites were shown to be enriched in SPMs (relative to unfractionated brain membranes) and, consistent with the hypothesis that acidic amino acids serve widespread transmitter functions in the CNS (Curtis and Johnston, 1974) , were present at high levels in the whole forebrain SPMs employed for this investigation (although note that there is a nonuniform distribution of these sites in the brain, with high densities in the hippocampus and brain stem; Monaghan et al., 1981) . Hence, the data presented here constitute a firm basis for proposing that the C11/Ca2'-dependent (APB-sensitive) Lglutamate binding sites are of physiological significance at acidic amino acid-using synapses in the CNS.
A number of investigators have shown previously that Ca2+ augments the binding of L-glutamate to various SPM preparations (Michaelis et al., 1974; Baudry and Lynch, 1979; Vargas and Costa, 1981) and that APB is an inhibitor of similar potency to that reported here (Foster and Roberts, 1978; Baudry and Lynch, 1981) . In all of these studies, Cl--containing buffers were utilized for the binding assay. In one investigation employing Tris-citrate buffer (Biziere et al., 1980) , APB was demonstrated to be of lower potency, and the general pharmacological profile for L-glutamate binding was somewhat different from that described by other authors (Foster and Roberts, 1978; Baudry and Lynch, 1981) . The findings of the present study, that there are two pharmacologically distinct populations of L-glutamate binding sites, one of which is revealed in the presence of Cl-(and Ca2+), help to reconcile these discrepancies.
The observation that Cl-stimulates L-glutamate binding to APB-sensitive sites was unexpected and merits discussion. Interestingly, those anions which mediate this effect (Mena et al., 1982) are the same anions which both modify the interaction of GABA antagonists (Enna and Snyder, 1977; Mohler and Okada, 1978) and benzodiazepines (Costa et al., 1979) with their recognition sites and permeate the neuronal membrane during postsynaptic inhibition (Araki et al., 1961) . In the GABA-benzodiazepine system, the receptor sites are thought to be linked to the membrane Cl-ion channel (Olsen, 1981 
